Company name | Market Cap | Profitability rating | Gross Profit margin (LTM) | EBIT margin (LTM) | EBITDA margin (LTM) | Net Income margin (LTM) | FCF margin (LTM) | Earnings quality (FCF to Net Income) |
$34.6B | 9.0 | 61.1% | 29.0% | 32.7% | 22.8% | 20.5% | 89.9% | |
$197.8B | 8.6 | 41.5% | 17.1% | 26.7% | 14.8% | 16.9% | 114.7% | |
$154.1B | 8.9 | 59.5% | 20.4% | 28.3% | 16.3% | 22.2% | 135.8% | |
$34.4B | 9.1 | 54.0% | 22.7% | 26.6% | 19.3% | 21.6% | 111.9% | |
$33.7B | 7.7 | 31.4% | 14.6% | 22.1% | 8.9% | 13.7% | 154.0% | |
$25.2B | 9.2 | 59.1% | 31.0% | 32.2% | 22.3% | 22.3% | 100.2% | |
$21.7B | 9.0 | 58.2% | 28.3% | 35.0% | 21.6% | 20.9% | 97.1% | |
$19.9B | 5.6 | 60.3% | (13.1%) | (8.5%) | (11.2%) | 4.1% | (36.4%) | |
$18.5B | 7.5 | 32.4% | 14.0% | 19.2% | 8.8% | 9.2% | 103.3% | |
$15.1B | 7.5 | 25.8% | 14.0% | 20.2% | 9.6% | 13.5% | 141.1% | |
$13.9B | 7.1 | 65.4% | 30.7% | (16.6%) | (28.0%) | 15.9% | (49.4%) |
The IDEXX Laboratories, Inc. (IDXX) gross profit margin is 61.1%, compared to the industry median of 48.7% and the 5-year historical average of 59.1%.
The IDEXX Laboratories, Inc. (IDXX) operating income margin is 28.5%, compared to the industry median of (11.6%)) and the 5-year historical average of 26.6%.
The IDEXX Laboratories, Inc. (IDXX) Free Cash Flow margin is 20.5%, compared to the industry median of (2.0%) and the 5-year historical average of 18.1%.
The IDEXX Laboratories, Inc. (IDXX) earnings quality is 89.9%, compared to the industry median of 96.8% and the 5-year historical average of 82.8%.